Risk factors analysis and prevention of metabolic bone disease of prematurity

Area of Science:

• Neonatology
• Pediatric Bone Health
• Perinatal Medicine

Background:

• Metabolic bone disease (MBD) of prematurity is a significant concern in neonatal intensive care.
• Identifying risk factors is crucial for timely intervention and prevention strategies.

Purpose of the Study:

• To analyze the risk factors associated with the development of MBD in preterm infants.
• To identify independent predictors for MBD in a cohort of extremely preterm neonates.

Main Methods:

• A case-control study involving 238 preterm infants (<34 weeks gestation) hospitalized for at least 6 weeks.
• Comparison of maternal, parturition, neonatal, and treatment-related factors between infants with MBD (cases) and those without (controls).
• Statistical analysis including t tests, chi-square tests, and logistic regression to determine independent risk factors.

Main Results:

• Infants with MBD had significantly lower gestational age and birth weight.
• Independent risk factors for MBD included birth before 30 weeks gestation, delayed vitamin D (VitD) supplementation (>14 days), and delayed achievement of total enteral nutrition (TEN) (>28 days).
• Other associated factors included small-for-gestational-age status, antenatal corticosteroid use, sedative use, ventilator use, diuretic use, and liver function impairment.

Conclusions:

• Gestational age <30 weeks, delayed VitD supplementation, and delayed TEN are independent risk factors for MBD in preterm infants.
• Early identification and management of these factors are essential for preventing MBD in high-risk neonates.
• This study provides evidence for targeted preventive measures in neonatal care settings.